Unknown

Dataset Information

0

Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.


ABSTRACT: Pediatric midline high-grade astrocytomas (mHGAs) are incurable with few treatment targets identified. Most tumors harbor mutations encoding p.Lys27Met in histone H3 variants. In 40 treatment-naive mHGAs, 39 analyzed by whole-exome sequencing, we find additional somatic mutations specific to tumor location. Gain-of-function mutations in ACVR1 occur in tumors of the pons in conjunction with histone H3.1 p.Lys27Met substitution, whereas FGFR1 mutations or fusions occur in thalamic tumors associated with histone H3.3 p.Lys27Met substitution. Hyperactivation of the bone morphogenetic protein (BMP)-ACVR1 developmental pathway in mHGAs harboring ACVR1 mutations led to increased levels of phosphorylated SMAD1, SMAD5 and SMAD8 and upregulation of BMP downstream early-response genes in tumor cells. Global DNA methylation profiles were significantly associated with the p.Lys27Met alteration, regardless of the mutant histone H3 variant and irrespective of tumor location, supporting the role of this substitution in driving the epigenetic phenotype. This work considerably expands the number of potential treatment targets and further justifies pretreatment biopsy in pediatric mHGA as a means to orient therapeutic efforts in this disease.

SUBMITTER: Fontebasso AM 

PROVIDER: S-EPMC4282994 | biostudies-literature | 2014 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma.

Fontebasso Adam M AM   Papillon-Cavanagh Simon S   Schwartzentruber Jeremy J   Nikbakht Hamid H   Gerges Noha N   Fiset Pierre-Olivier PO   Bechet Denise D   Faury Damien D   De Jay Nicolas N   Ramkissoon Lori A LA   Corcoran Aoife A   Jones David T W DT   Sturm Dominik D   Johann Pascal P   Tomita Tadanori T   Goldman Stewart S   Nagib Mahmoud M   Bendel Anne A   Goumnerova Liliana L   Bowers Daniel C DC   Leonard Jeffrey R JR   Rubin Joshua B JB   Alden Tord T   Browd Samuel S   Geyer J Russell JR   Leary Sarah S   Jallo George G   Cohen Kenneth K   Gupta Nalin N   Prados Michael D MD   Carret Anne-Sophie AS   Ellezam Benjamin B   Crevier Louis L   Klekner Almos A   Bognar Laszlo L   Hauser Peter P   Garami Miklos M   Myseros John J   Dong Zhifeng Z   Siegel Peter M PM   Malkin Hayley H   Ligon Azra H AH   Albrecht Steffen S   Pfister Stefan M SM   Ligon Keith L KL   Majewski Jacek J   Jabado Nada N   Kieran Mark W MW  

Nature genetics 20140406 5


Pediatric midline high-grade astrocytomas (mHGAs) are incurable with few treatment targets identified. Most tumors harbor mutations encoding p.Lys27Met in histone H3 variants. In 40 treatment-naive mHGAs, 39 analyzed by whole-exome sequencing, we find additional somatic mutations specific to tumor location. Gain-of-function mutations in ACVR1 occur in tumors of the pons in conjunction with histone H3.1 p.Lys27Met substitution, whereas FGFR1 mutations or fusions occur in thalamic tumors associate  ...[more]

Similar Datasets

| S-EPMC4827050 | biostudies-literature
| S-EPMC8277861 | biostudies-literature
| S-EPMC4357229 | biostudies-literature
| S-EPMC9853562 | biostudies-literature
| S-EPMC8381557 | biostudies-literature
| S-EPMC4018681 | biostudies-literature
| S-EPMC3951336 | biostudies-literature
| S-EPMC3600584 | biostudies-literature
2021-10-20 | GSE163656 | GEO
2013-11-06 | E-GEOD-46190 | biostudies-arrayexpress